Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...
The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...
At least one Woodward pharmacist is celebrating an action by Oklahoma Attorney General Gentner Drummond that could turn the ...
The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Independent drugstores are closing at an alarming rate, squeezed by the huge companies that reimburse pharmacies for costly ...
Senate Democrats have unveiled two bills aimed at bringing down the cost of both healthcare and health insurance in ...
As PBM services have traditionally been dominated by large companies such as CVS Caremark, Express Scripts and OptumRx, health systems are starting to create alternatives. Here are four more things to ...
Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the ...
Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C., talks about the problems associated with generic HIV PrEP drug markups and potential ways to fix it.
Arbitrator Stuart Widman found that Prime violated federal and state antitrust laws by engaging in price-fixing agreements with Express Scripts, another major PBM, according to a Jan. 23 news release ...